659 related articles for article (PubMed ID: 24370644)
21. Histologic factors affecting prognosis following hepatectomy for intrahepatic cholangiocarcinoma.
Uenishi T; Hirohashi K; Kubo S; Yamamoto T; Hamba H; Tanaka H; Kinoshita H
World J Surg; 2001 Jul; 25(7):865-9. PubMed ID: 11572025
[TBL] [Abstract][Full Text] [Related]
22. Outcomes after curative hepatectomy in patients with non-B non-C hepatocellular carcinoma and hepatitis B virus hepatocellular carcinoma from non-cirrhotic liver.
Kim JM; Kwon CH; Joh JW; Park JB; Lee JH; Kim SJ; Paik SW; Park CK; Yoo BC
J Surg Oncol; 2014 Dec; 110(8):976-81. PubMed ID: 25171344
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors of distal cholangiocarcinoma after curative surgery: a series of 84 cases.
Tan X; Xiao K; Liu W; Chang S; Zhang T; Tang H
Hepatogastroenterology; 2013; 60(128):1892-5. PubMed ID: 24719923
[TBL] [Abstract][Full Text] [Related]
24. Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation.
Seo JY; Kim W; Kwon JH; Jin EH; Yu SJ; Kim HY; Jung YJ; Kim D; Kim YJ; Yoon JH; Lee HS
Liver Int; 2013 Jul; 33(6):884-93. PubMed ID: 23461618
[TBL] [Abstract][Full Text] [Related]
25. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
[TBL] [Abstract][Full Text] [Related]
26. Comparison of resection and transarterial chemoembolisation in the treatment of advanced intrahepatic cholangiocarcinoma--a single-center experience.
Scheuermann U; Kaths JM; Heise M; Pitton MB; Weinmann A; Hoppe-Lotichius M; Otto G
Eur J Surg Oncol; 2013 Jun; 39(6):593-600. PubMed ID: 23611755
[TBL] [Abstract][Full Text] [Related]
27. Comparison of clinical characteristics of combined hepatocellular-cholangiocarcinoma and other primary liver cancers.
Lee CH; Hsieh SY; Chang CJ; Lin YJ
J Gastroenterol Hepatol; 2013 Jan; 28(1):122-7. PubMed ID: 23034166
[TBL] [Abstract][Full Text] [Related]
28. Prognostic impact of hepatitis B virus infection in patients with intrahepatic cholangiocarcinoma.
Ahn CS; Hwang S; Lee YJ; Kim KH; Moon DB; Ha TY; Song GW; Lee SG
ANZ J Surg; 2018 Mar; 88(3):212-217. PubMed ID: 27598539
[TBL] [Abstract][Full Text] [Related]
29. The long-term outcomes after curative resection for mass-forming intrahepatic cholangiocarcinoma associated with hepatitis C viral infection: a multicenter analysis by Osaka Hepatic Surgery Study Group.
Uenishi T; Nagano H; Marubashi S; Hayashi M; Hirokawa F; Kaibori M; Matsui K; Kubo S
J Surg Oncol; 2014 Aug; 110(2):176-81. PubMed ID: 24760391
[TBL] [Abstract][Full Text] [Related]
30. Correlation between smoking habit and surgical outcomes on viral-associated hepatocellular carcinomas.
Kai K; Komukai S; Koga H; Yamaji K; Ide T; Kawaguchi A; Aishima S; Noshiro H
World J Gastroenterol; 2018 Jan; 24(1):58-68. PubMed ID: 29358882
[TBL] [Abstract][Full Text] [Related]
31. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.
Chantajitr S; Wilasrusmee C; Lertsitichai P; Phromsopha N
J Hepatobiliary Pancreat Surg; 2006; 13(6):537-42. PubMed ID: 17139428
[TBL] [Abstract][Full Text] [Related]
32. Transplantation versus resection for patients with combined hepatocellular carcinoma-cholangiocarcinoma.
Groeschl RT; Turaga KK; Gamblin TC
J Surg Oncol; 2013 May; 107(6):608-12. PubMed ID: 23386397
[TBL] [Abstract][Full Text] [Related]
33. Longterm prognosis of combined hepatocellular carcinoma-cholangiocarcinoma following liver transplantation and resection.
Jung DH; Hwang S; Song GW; Ahn CS; Moon DB; Kim KH; Ha TY; Park GC; Hong SM; Kim WJ; Kang WH; Kim SH; Yu ES; Lee SG
Liver Transpl; 2017 Mar; 23(3):330-341. PubMed ID: 28027599
[TBL] [Abstract][Full Text] [Related]
34. Is hepatic resection for recurrent or persistent hepatocellular carcinoma justified?
Kishi Y; Saiura A; Yamamoto J; Koga R; Seki M; Morimura R; Yoshioka R; Kokudo N; Yamaguch T
Hepatogastroenterology; 2012 Oct; 59(119):2255-9. PubMed ID: 23435140
[TBL] [Abstract][Full Text] [Related]
35. Characteristics of combined hepatocelluar-cholangiocarcinoma and comparison with intrahepatic cholangiocarcinoma.
Kim SH; Park YN; Lim JH; Choi GH; Choi JS; Kim KS
Eur J Surg Oncol; 2014 Aug; 40(8):976-81. PubMed ID: 24909336
[TBL] [Abstract][Full Text] [Related]
36. α-Fetoprotein is a potential survival predictor in hepatocellular carcinoma patients with hepatitis B selected for liver transplantation.
Zhang Q; Shang L; Zang Y; Chen X; Zhang L; Wang Y; Wang L; Liu Y; Mao S; Shen Z
Eur J Gastroenterol Hepatol; 2014 May; 26(5):544-52. PubMed ID: 24614696
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.
Shirabe K; Mano Y; Taketomi A; Soejima Y; Uchiyama H; Aishima S; Kayashima H; Ninomiya M; Maehara Y
Ann Surg Oncol; 2010 Jul; 17(7):1816-22. PubMed ID: 20135355
[TBL] [Abstract][Full Text] [Related]
38. Postresection Outcomes of Combined Hepatocellular Carcinoma-Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Yoon YI; Hwang S; Lee YJ; Kim KH; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Lee JW; Hong SM; Yu ES; Lee SG
J Gastrointest Surg; 2016 Feb; 20(2):411-20. PubMed ID: 26628072
[TBL] [Abstract][Full Text] [Related]
39. Predictive factors of recurrence for patients with intrahepatic cholangiocarcinoma after hepatectomy.
Chen LP; Li C; Wang C; Wen TF; Yan LN; Li B
Hepatogastroenterology; 2012 Sep; 59(118):1765-8. PubMed ID: 22369746
[TBL] [Abstract][Full Text] [Related]
40. Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients.
Rea DJ; Munoz-Juarez M; Farnell MB; Donohue JH; Que FG; Crownhart B; Larson D; Nagorney DM
Arch Surg; 2004 May; 139(5):514-23; discussion 523-5. PubMed ID: 15136352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]